Startups & Innovation

NIH SBIR Phase IIB Strategic Breakthrough Award (R44) — PA-27-101

NIH / HHS Federal

Award
Institute-specific, often $3M+ over up to 3 yrs
Status & deadline
Open Std due dates Sep 5, 2026 / Jan 5, 2027 / Apr 5, 2027
Where
All states

About this grant

Bridges the funding gap between Phase II and market for breakthrough technologies.

Who it's for

Firms with an active/prior NIH Phase II needing additional funds to reach commercialization.

View the funder's grant page ↗

Want this one filed for you?

Tell us about your business and our staff will screen your fit, then prepare, assemble, and file the application for your review and approval — and walk you through what it costs on a short call first.

Have our AI staff write this application

No obligation, and no one can guarantee an award — we only submit where you genuinely qualify, complete and on time.